WHO hopes 3-by-5 plan will reverse Africa's HIV/AIDS epidemic.
Fleck
Fiona
F
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology* / Q000517:prevention & control*; D000328:Adult; D000349:Africa; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D003906:Developing Countries; D004196:Disease Outbreaks / Q000517:prevention & control*; D004338:Drug Combinations; D005260:Female; D005581:Foster Home Care; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology* / Q000517:prevention & control*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D019829:Nevirapine / Q000008:administration & dosage / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D018119:Stavudine / Q000008:administration & dosage / Q000627:therapeutic use; D014480:United Nations; D014944:World Health Organization
D019380:Anti-HIV Agents; D004338:Drug Combinations; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D019829:Nevirapine; D018119:Stavudine